Novel approach for estrogen-receptor-positive breast cancer reported — ScienceDaily
The new approach, a new drug class called gamma secretase inhibitors (GSI), specifically inhibits Notch and shuts down critical genes and cancer cells responsible for tumor growth. Kathy Albain, MD, FACP, who led the study, will present findings Dec. …